IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $789,049 | -28.4% | 41,815 | -85.4% | 0.00% | – |
| Q1 2023 | $1,101,569 | -22.8% | 286,867 | -0.3% | 0.00% | – |
| Q4 2022 | $1,427,000 | +139.4% | 287,749 | +130.6% | 0.00% | – |
| Q3 2022 | $596,000 | +4.9% | 124,765 | -1.1% | 0.00% | – |
| Q2 2022 | $568,000 | -5.0% | 126,216 | +0.5% | 0.00% | – |
| Q1 2022 | $598,000 | -98.7% | 125,540 | -97.8% | 0.00% | -100.0% |
| Q1 2021 | $45,324,000 | +278.3% | 5,595,683 | +201.2% | 0.02% | +275.0% |
| Q4 2020 | $11,981,000 | +134.7% | 1,857,493 | +31.0% | 0.00% | +100.0% |
| Q3 2020 | $5,104,000 | -22.8% | 1,417,636 | -1.4% | 0.00% | -33.3% |
| Q2 2020 | $6,612,000 | +7771.4% | 1,437,149 | +5746.6% | 0.00% | – |
| Q1 2020 | $84,000 | -28.2% | 24,581 | +7.1% | 0.00% | – |
| Q4 2019 | $117,000 | +134.0% | 22,962 | +10.7% | 0.00% | – |
| Q3 2019 | $50,000 | -96.0% | 20,748 | -83.8% | 0.00% | -100.0% |
| Q2 2018 | $1,243,000 | +11.6% | 127,776 | +20.7% | 0.00% | 0.0% |
| Q1 2018 | $1,114,000 | -30.2% | 105,904 | -49.2% | 0.00% | 0.0% |
| Q3 2017 | $1,595,000 | +2.8% | 208,574 | -4.5% | 0.00% | 0.0% |
| Q2 2017 | $1,552,000 | +1.6% | 218,393 | -44.7% | 0.00% | 0.0% |
| Q1 2017 | $1,528,000 | +1398.0% | 394,770 | +3193.0% | 0.00% | – |
| Q1 2016 | $102,000 | -56.2% | 11,988 | -30.1% | 0.00% | – |
| Q4 2015 | $233,000 | +62.9% | 17,138 | +15.0% | 0.00% | – |
| Q3 2015 | $143,000 | -32.5% | 14,905 | +1.1% | 0.00% | – |
| Q2 2015 | $212,000 | +96.3% | 14,747 | +22.5% | 0.00% | – |
| Q1 2015 | $108,000 | +58.8% | 12,043 | +87.7% | 0.00% | – |
| Q3 2014 | $68,000 | +161.5% | 6,415 | +195.2% | 0.00% | – |
| Q2 2014 | $26,000 | +225.0% | 2,173 | +336.3% | 0.00% | – |
| Q1 2014 | $8,000 | -38.5% | 498 | -43.3% | 0.00% | – |
| Q4 2013 | $13,000 | -86.9% | 878 | -84.8% | 0.00% | – |
| Q3 2013 | $99,000 | 0.0% | 5,772 | -3.7% | 0.00% | – |
| Q2 2013 | $99,000 | – | 5,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |